Assembly Biosciences press release ( ASMB ): Q1 GAAP EPS of -$0.54 beats by $0.03 . Revenue of $8.21M (-12.8% Y/Y) beats by $1.26M . More on Assembly Biosciences Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for...
Assembly Biosciences press release ( ASMB ): Q1 GAAP EPS of -$0.54 beats by $0.03 . Revenue of $8.21M (-12.8% Y/Y) beats by $1.26M . More on Assembly Biosciences Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Biosciences
Abacus Global Management press release ( ABX ): Q1 Non-GAAP EPS of $0.20 misses by $0.01 . Revenue of $59.39M (+34.7% Y/Y) misses by $6.08M . Outlook Metric FY26 2Q26 Note Adjusted net income 1 $100M to $106M $24M to $26M FY Implies 17% to Click to enlarge
Abacus Global Management press release ( ABX ): Q1 Non-GAAP EPS of $0.20 misses by $0.01 . Revenue of $59.39M (+34.7% Y/Y) misses by $6.08M . Outlook Metric FY26 2Q26 Note Adjusted net income 1 $100M to $106M $24M to $26M FY Implies 17% to Click to enlarge
IQVIA Holdings ( IQV ) on Thursday announced that its board of directors authorized the repurchase of an additional $2 billion of IQVIA’s common stock under IQVIA’s existing equity repurchase program, bringing the total remaining authorization to $3.2 billion. Press release More on IQVIA IQVIA Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation IQVIA Holdings Inc. (IQV) Q1 2026 Earnings C...
IQVIA Holdings ( IQV ) on Thursday announced that its board of directors authorized the repurchase of an additional $2 billion of IQVIA’s common stock under IQVIA’s existing equity repurchase program, bringing the total remaining authorization to $3.2 billion. Press release More on IQVIA IQVIA Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Iqvia signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue IQVIA Non-GAAP EPS of $2.90 beats by $0.08, revenue of $4.15B beats by $50M
MARKHAM, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2026.
MARKHAM, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2026.
Varex Imaging press release ( VREX ): Q2 Non-GAAP EPS of $0.21 in-line. Revenue of $216M (+1.5% Y/Y) misses by $0.92M . Guidance for the third quarter of fiscal year 2026 is as follows: Revenues are expected to be between $210 million and $225 million
Varex Imaging press release ( VREX ): Q2 Non-GAAP EPS of $0.21 in-line. Revenue of $216M (+1.5% Y/Y) misses by $0.92M . Guidance for the third quarter of fiscal year 2026 is as follows: Revenues are expected to be between $210 million and $225 million
Every LangChain pipeline your team hardcodes starts breaking the moment the query distribution shifts — and it always shifts. That bottleneck is what Sakana AI set out to eliminate. Researchers at Sakana AI have introduced the " RL Conductor ," a small language model trained via reinforcement learning to automatically orchestrate a diverse pool of worker LLMs. Conductor dynamically analyzes inputs...
Every LangChain pipeline your team hardcodes starts breaking the moment the query distribution shifts — and it always shifts. That bottleneck is what Sakana AI set out to eliminate. Researchers at Sakana AI have introduced the " RL Conductor ," a small language model trained via reinforcement learning to automatically orchestrate a diverse pool of worker LLMs. Conductor dynamically analyzes inputs, distributes labor among workers, and coordinates among agents. This automated coordination achieves state-of-the-art results on difficult reasoning and coding benchmarks, outperforming individual frontier models like GPT-5 and Claude Sonnet 4 as well as expensive human-designed multi-agent pipelines. It achieves this performance at a fraction of the cost and with fewer API calls than competitors. RL Conductor is the backbone of Fugu, Sakana AI’s commercial multi-agent orchestration service. The limitations of manual agentic frameworks Large language models have strong latent capabilities. But tapping these capabilities to their fullest is a great challenge. Extracting this level of performance relies heavily on manually designed agentic workflows, which serve as critical components in commercial AI products. However, these frameworks fall short because they are inherently rigid and constrained. In comments to VentureBeat, Yujin Tang, co-author of the paper, explained the exact breaking point of current systems: "While using frameworks with hard-coded pipelines like LangChain and Mixture-of-Agents can work well for specific use cases … In production, an inherent bottleneck arises when targeting domains with large user bases with very heterogeneous demands." Tang noted that achieving "real-world generalization in such heterogeneous applications inherently necessitates going beyond human-hardcoded designs." Another bottleneck for building robust agentic systems is that no single model is optimal for all tasks. Different models are fine-tuned to specialize in distinct domains...
Alector press release ( ALEC ): Q1 GAAP EPS of -$0.21 beats by $0.06 . Revenue of $1.05M (-71.4% Y/Y) misses by $9.98M . More on Alector Alector, Inc. (ALEC) Discusses Blood-Brain Barrier Platform and Pipeline for Neurodegenerative Diseases Transcript Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Tran...
Alector press release ( ALEC ): Q1 GAAP EPS of -$0.21 beats by $0.06 . Revenue of $1.05M (-71.4% Y/Y) misses by $9.98M . More on Alector Alector, Inc. (ALEC) Discusses Blood-Brain Barrier Platform and Pipeline for Neurodegenerative Diseases Transcript Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript Alector halts mid-stage trial for Alzheimer’s candidate developed with GSK Alector gains as Cantor Fitzgerald upgrades on brain carrier platform
Alta Equipment press release ( ALTG ): Q1 Non-GAAP EPS of -$0.55 misses by $0.08 . Revenue of $410.5M (-3.0% Y/Y) misses by $13.68M . Material Handling and Construction Equipment segments new and used equipment sales gross profit margins both remained stable year over
Alta Equipment press release ( ALTG ): Q1 Non-GAAP EPS of -$0.55 misses by $0.08 . Revenue of $410.5M (-3.0% Y/Y) misses by $13.68M . Material Handling and Construction Equipment segments new and used equipment sales gross profit margins both remained stable year over
Leon Neal/Getty Images News Wall Street’s major market averages finished lower on Thursday following the previous session’s rally. The blue chip Dow ( DJI ) ended -0.6%, the benchmark S&P 500 ( SP500 ) closed -0.3%, and the tech-focused Nasdaq Composite ( COMP:IND ) handed back -0.1%. Now, here are the
Leon Neal/Getty Images News Wall Street’s major market averages finished lower on Thursday following the previous session’s rally. The blue chip Dow ( DJI ) ended -0.6%, the benchmark S&P 500 ( SP500 ) closed -0.3%, and the tech-focused Nasdaq Composite ( COMP:IND ) handed back -0.1%. Now, here are the
The dollar index (DXY00 ) on Thursday rose by +0.14%. The dollar recovered from early losses on Thursday and moved higher after stocks gave up early gains and turned lower, boosting liquidity demand for the dollar. The dollar also found support on Thursday’s dollar-friendly news on weekly jobless claims, Q1...
The dollar index (DXY00 ) on Thursday rose by +0.14%. The dollar recovered from early losses on Thursday and moved higher after stocks gave up early gains and turned lower, boosting liquidity demand for the dollar. The dollar also found support on Thursday’s dollar-friendly news on weekly jobless claims, Q1...
Earnings Call Insights: Iovance Biotherapeutics (IOVA) Q1 2026 Management View "During the first quarter of 2026, we drove Amtagvi adoption, advanced our development pipeline, and streamlined costs and efficiencies," said "First quarter revenue grew approximately 45% year-over-year," according to (Interim CEO, President, General Counsel, Corporate Secretary & Director Frederick Vogt).
Earnings Call Insights: Iovance Biotherapeutics (IOVA) Q1 2026 Management View "During the first quarter of 2026, we drove Amtagvi adoption, advanced our development pipeline, and streamlined costs and efficiencies," said "First quarter revenue grew approximately 45% year-over-year," according to (Interim CEO, President, General Counsel, Corporate Secretary & Director Frederick Vogt).
monsitj/iStock via Getty Images Gold futures rose slightly to a two-week high Thursday as traders weighed the potential for a U.S.-Iran peace deal that could reopen the Strait of Hormuz, which also sent the dollar and crude oil lower, although gains were capped after a report said
monsitj/iStock via Getty Images Gold futures rose slightly to a two-week high Thursday as traders weighed the potential for a U.S.-Iran peace deal that could reopen the Strait of Hormuz, which also sent the dollar and crude oil lower, although gains were capped after a report said
Earnings Call Insights: Howmet Aerospace (HWM) Q1 2026 Management View "Howmet had a very strong start to 2026" with "Sales ... $2.31 billion, EBITDA of $740 million and earnings per share of $1.22" and "Cash generation was $359 million" (Executive Chairman & CEO John Plant).
Earnings Call Insights: Howmet Aerospace (HWM) Q1 2026 Management View "Howmet had a very strong start to 2026" with "Sales ... $2.31 billion, EBITDA of $740 million and earnings per share of $1.22" and "Cash generation was $359 million" (Executive Chairman & CEO John Plant).
Nature's Sunshine press release ( NATR ): Q1 Non-GAAP EPS of $0.30 beats by $0.10 . Revenue of $122.9M (+8.6% Y/Y) beats by $0.73M . Outlook Nature's Sunshine continues to expect 2026 net sales to range between $500 - $515 million and adjusted EBITDA to range between $50 - $54
Nature's Sunshine press release ( NATR ): Q1 Non-GAAP EPS of $0.30 beats by $0.10 . Revenue of $122.9M (+8.6% Y/Y) beats by $0.73M . Outlook Nature's Sunshine continues to expect 2026 net sales to range between $500 - $515 million and adjusted EBITDA to range between $50 - $54
PRA Group press release ( PRAA ): Q1 GAAP EPS of $0.73 beats by $0.22 . Revenue of $313.46M (+16.3% Y/Y) beats by $17.52M . More on PRA Group PRA Group: Not Cheap Enough Yet PRA Group, Inc. 2025 Q4 - Results - Earnings Call Presentation PRA Group: A Better Quarter Is Welcome, But A Lot Of Work Remains PRA Group Q1 2026 Earnings Preview PRA Group outlines $1B–$1.3B annual investment plan while adva...
PRA Group press release ( PRAA ): Q1 GAAP EPS of $0.73 beats by $0.22 . Revenue of $313.46M (+16.3% Y/Y) beats by $17.52M . More on PRA Group PRA Group: Not Cheap Enough Yet PRA Group, Inc. 2025 Q4 - Results - Earnings Call Presentation PRA Group: A Better Quarter Is Welcome, But A Lot Of Work Remains PRA Group Q1 2026 Earnings Preview PRA Group outlines $1B–$1.3B annual investment plan while advancing AI and cost management initiatives
TWFG press release ( TWFG ): Q1 Non-GAAP EPS of $0.29 beats by $0.09 . Revenue of $72.8M (+35.3% Y/Y) beats by $5.8M . Total Written Premium for the quarter increased 23.5% to $458.2 million, compared to $371.0 million in the prior year period
TWFG press release ( TWFG ): Q1 Non-GAAP EPS of $0.29 beats by $0.09 . Revenue of $72.8M (+35.3% Y/Y) beats by $5.8M . Total Written Premium for the quarter increased 23.5% to $458.2 million, compared to $371.0 million in the prior year period
IREN Limited press release ( IREN ): Q3 Net income (loss) of $(247.8)m (vs. Q2 FY26 $(155.4)m) Adj. EBITDA decreased to $59.5m (vs. Q2 FY26 $75.3m) Revenue of $144.8M (-21.6% Y/Y) misses by $74.49M . $3.4bn AI Cloud contract with NVIDIA 5-year contract for air-cooled Blackwell GPUs Deploying within 60MW of existing data centers at Childress Targeting ramp from early 2027 More on IREN Limited IREN:...
IREN Limited press release ( IREN ): Q3 Net income (loss) of $(247.8)m (vs. Q2 FY26 $(155.4)m) Adj. EBITDA decreased to $59.5m (vs. Q2 FY26 $75.3m) Revenue of $144.8M (-21.6% Y/Y) misses by $74.49M . $3.4bn AI Cloud contract with NVIDIA 5-year contract for air-cooled Blackwell GPUs Deploying within 60MW of existing data centers at Childress Targeting ramp from early 2027 More on IREN Limited IREN: Show Me The AI Revenue IREN Limited: The Moat Has Shifted; It's No Longer A Mining Story IREN: I Am Still Bullish Despite The Prove-It Phase IREN to acquire Spain’s Nostrum Group in expansion into Europe IREN to buy Mirantis for $625M in stock
Earnings Call Insights: Tecnoglass (TGLS) Q1 2026 Management View CEO Jose Daes said demand remained “favorable,” adding that “our backlog is at a record level and order activity across both our commercial and single-family residential businesses continues to build momentum.”
Earnings Call Insights: Tecnoglass (TGLS) Q1 2026 Management View CEO Jose Daes said demand remained “favorable,” adding that “our backlog is at a record level and order activity across both our commercial and single-family residential businesses continues to build momentum.”
Kodiak AI, Inc. press release ( KDK ): Q1 GAAP EPS of $0.10 beats by $0.30 . Revenue of $1.83M (+24.5% Y/Y) beats by $0.18M . Shares -34.7% AH. More on Kodiak AI, Inc. Kodiak AI: Strong In Unstructured Environments, But Short Cash Runway Is A Concern Kodiak AI: Growth At A High Cost Kodiak AI, Inc. (KDK) Q4 2025 Earnings Call Transcript Kodiak AI rallies after its autonomous driving system is task...
Kodiak AI, Inc. press release ( KDK ): Q1 GAAP EPS of $0.10 beats by $0.30 . Revenue of $1.83M (+24.5% Y/Y) beats by $0.18M . Shares -34.7% AH. More on Kodiak AI, Inc. Kodiak AI: Strong In Unstructured Environments, But Short Cash Runway Is A Concern Kodiak AI: Growth At A High Cost Kodiak AI, Inc. (KDK) Q4 2025 Earnings Call Transcript Kodiak AI rallies after its autonomous driving system is tasked to help combat attack drones Seeking Alpha’s Quant Rating on Kodiak AI, Inc.
(RTTNews) - Thursday, ICU Medical, Inc. (ICUI) announced its first-quarter financial results, reporting a net income of $30.1 million, or $1.20 a share, compared with a net loss of $15.5 million, or $0.63 a share, in the prior year.
(RTTNews) - Thursday, ICU Medical, Inc. (ICUI) announced its first-quarter financial results, reporting a net income of $30.1 million, or $1.20 a share, compared with a net loss of $15.5 million, or $0.63 a share, in the prior year.
Starz Entertainment Corp. press release ( STRZ ): Q1 GAAP EPS of -$9.83 misses by $8.55 . Revenue of $306.9M beats by $1.15M . As of March 31, 2026, key balance sheet metrics included: Cash and cash equivalents: $102.1 million Total debt: $625.1 million, including a $300.0
Starz Entertainment Corp. press release ( STRZ ): Q1 GAAP EPS of -$9.83 misses by $8.55 . Revenue of $306.9M beats by $1.15M . As of March 31, 2026, key balance sheet metrics included: Cash and cash equivalents: $102.1 million Total debt: $625.1 million, including a $300.0
Kodiak Sciences press release ( KOD ): Q1 GAAP EPS of -$0.94 beats by $0.07 . Kodiak ended the first quarter of 2026 with $169.5 of million cash and cash equivalents. We believe that our current cash and cash equivalents will support our current and planned operations into 2027. More on Kodiak Sciences Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines Kodiak Scien...
Kodiak Sciences press release ( KOD ): Q1 GAAP EPS of -$0.94 beats by $0.07 . Kodiak ended the first quarter of 2026 with $169.5 of million cash and cash equivalents. We believe that our current cash and cash equivalents will support our current and planned operations into 2027. More on Kodiak Sciences Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026 - Slideshow Kodiak climbs on late-stage trial win for diabetic retinopathy therapy Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences